Gene: TEX30
Official Full Name: testis expressed 30provided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO22375 | TEX30 Knockout cell line (HeLa) | Human | TEX30 | 1:3~1:6 | Negative | Online Inquiry |
KO22376 | TEX30 Knockout cell line (HCT 116) | Human | TEX30 | 1:2~1:4 | Negative | Online Inquiry |
KO22377 | TEX30 Knockout cell line (HEK293) | Human | TEX30 | 1:3~1:6 | Negative | Online Inquiry |
KO22378 | TEX30 Knockout cell line (A549) | Human | TEX30 | 1:3~1:4 | Negative | Online Inquiry |
TEX30 Gene Knockout Cell Lines are advanced research tools specifically engineered to disable the expression of the TEX30 gene. These cell lines provide scientists with a vital asset for understanding the functional role of TEX30 in various biological processes, including cell signaling, development, and disease pathology. By creating models that lack this specific gene, researchers can evaluate the downstream effects on cellular behavior and interactions, thus gaining insights into its contributions to health and disease.
The mechanism of TEX30 gene knockout relies on CRISPR-Cas9 technology, granting precise genomic editing capabilities. This cutting-edge approach facilitates the targeted disruption of the gene within the cell's genomic architecture, leading to the generation of stable knockout models. As a result, these cell lines exhibit dramatic alterations in cellular functions, which can be analyzed through various assays, including proliferation, differentiation, and response to external stimuli.
The scientific importance of TEX30 Gene Knockout Cell Lines is underscored by their applications in both basic research and clinical investigations. They serve as invaluable tools for elucidating the pathophysiological mechanisms of diseases related to TEX30, including cancer, neurodegenerative disorders, and other genetic conditions. Moreover, these cell lines are instrumental in drug discovery and therapeutic testing, allowing for high-throughput screening of potential treatments targeting pathways influenced by TEX30.
What sets TEX30 Gene Knockout Cell Lines apart from alternative models is their unparalleled genetic specificity and reliability. Unlike traditional knockdown methods, which may only reduce expression levels, the complete knockout of TEX30 enables definitive conclusions regarding its role in cellular processes. The availability of these models significantly accelerates research timelines and enhances the reproducibility of experimental outcomes.
For researchers and clinicians committed to unraveling the complexities of gene function and developing novel therapies, TEX30 Gene Knockout Cell Lines offer unprecedented value. With our company's extensive expertise in genetic engineering and commitment to quality, we ensure that each cell line is rigorously validated and characterized, providing you with a robust platform for your most demanding research applications.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.